SG/CALL/NOVO-NORDISK B/1160/0.1/21.06.24 Stock

Warrant

DE000SW7HUN2

Market Closed - Boerse Frankfurt Warrants 15:47:36 2024-05-17 EDT
0.001 EUR 0.00% Intraday chart for SG/CALL/NOVO-NORDISK B/1160/0.1/21.06.24
Current month-96.97%
1 month-97.30%
Date Price Change
24-05-17 0.001 0.00%
24-05-16 0.001 -75.00%
24-05-15 0.004 -77.78%
24-05-14 0.018 +80.00%
24-05-13 0.01 +25.00%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 03:47 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SW7HUN
ISINDE000SW7HUN2
Date issued 2024-03-11
Strike 1,160 kr
Maturity 2024-06-21 (35 Days)
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.21
Lowest since issue 0.001
Delta0x
Omega 0.000000
Premium0x
Gearing1008.01x
Moneyness 0.7787
Difference Strike 256.7 kr
Difference Strike %+22.13%
Spread 0.022
Spread %95.65%
Intrinsic value 0.000000
Present value 0.0120

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
903.3 DKK
Average target price
909.2 DKK
Spread / Average Target
+0.66%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW